European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-05-24

European multiple system atrophy study group

Cel

Multiple system atrophy (MSA) is a progressive neurodegenerative disorder, which frequently presents with the features of Parkinson's Disease, but in contrast to latter, causes early death and prolonged severe disability. The proposed concerted action will pave the way towards neuroprotective intervention trials in MSA by developing a trial protocol 'CAPIT-MSA) and by implementing a central MSA Registry (EMSA-R) for centralized data acquisition during a multicoated natural history study that will enable us to define rates of disease progression and to validate the CAPIT-MSA protocol. Furthermore, candidate neuroprotective agents will be screened in proof of concept studies using an established animal model of striatonigral degeneration. Pending ongoing preclinical safety and phase I studies of these agents by the industrial partners, one of the agents will be selected foray multicoated safety and tolerability phase II trial commencing at month 18.

Dziedzina nauki

Program(-y)

Temat(-y)

Zaproszenie do składania wniosków

Data not available

System finansowania

CON - Coordination of research actions

Koordynator

UNIVERSITY HOSPITAL INNSBRUCK
Wkład UE
Brak danych
Adres
Anichstrasse 35
6020 INNSBRUCK
Austria

Zobacz na mapie
Koszt całkowity
Brak danych

Uczestnicy (20)

Udostępnij tę stronę

Pobierz

Ostatnia aktualizacja: 12 Kwietnia 2005

Moja broszura

Permalink: https://cordis.europa.eu/project/id/QLK6-CT-2000-00661/pl

European Union, 2024